enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. FDA Approves AbbVie's Parkinson's Treatment, Medicare ... - AOL

   www.aol.com/finance/fda-approves-abbvies...

   On Thursday, the FDA approved AbbVie Inc’s (NYSE:ABBV) Vyalev (foscarbidopa and foslevodopa) as the first and only subcutaneous 24-hour infusion of levodopa-based therapy for motor fluctuations ...

3. Injectable drug to ease advanced Parkinson's disease ... - AOL

   www.aol.com/injectable-drug-ease-advanced...

   "For too long, the Parkinson's community has had limited treatment options for advanced disease," Dr. Robert A. Hauser, professor of neurology at the University of South Florida said in a press ...

4. A Potential Parkinson's Treatment Has Promising Results - AOL

   www.aol.com/potential-parkinsons-treatment...

   A small new trial published in the journal Nature Medicine describes what would be two firsts for Parkinson's disease, if they pan out: a diagnostic test and a potential immune-based treatment ...

5. Management of Parkinson's disease - Wikipedia

   en.wikipedia.org/wiki/Management_of_Parkinson's...

   In the management of Parkinson's disease, due to the chronic nature of Parkinson's disease (PD), a broad-based program is needed that includes patient and family education, support-group services, general wellness maintenance, exercise, and nutrition. At present, no cure for the disease is known, but medications or surgery can provide relief ...

6. Tavapadon - Wikipedia

   en.wikipedia.org/wiki/Tavapadon

   Tavapadon (developmental code names CVL-751, PF-06649751) is a dopamine receptor agonist which is under development for the treatment of Parkinson's disease. [2] [3] [4] It is under development by Cerevel Therapeutics, which acquired tavapadon from Pfizer in 2018. [2]

7. Gene therapy in Parkinson's disease - Wikipedia

   en.wikipedia.org/wiki/Gene_therapy_in_Parkinson's...

   However, with this treatment, the number of substantia nigra neurons decrease so it becomes less efficient. [2] These treatments try to reduce the symptoms of the patient focusing on increasing the production of dopamine but they do not cure the disease. The new treatments for PD are in clinical trials and most of them are centered on gene therapy.